PATENT CLAIM ANALYSIS

Application Number: 16137167
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "531000"]

Abstract:
The present specification provides methods of treating disease with an ester of an RXR agonist or a combination of an ester of an RXR agonist and a thyroid hormone. The esters of an RXR agonist can be useful in the treatment of cancer, nervous system, autoimmune, and muscular disorders.

Claim (Index 25):
The method of  claim 24 , wherein the dosage is up to 24, 40, 60, 80, 100, or 120 mg/m 2 /day.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 97.0
- Lexical Diversity: 1.58824
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16118001', '15812821', '15339752', '15339762', '14507730']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8665405292761047
- 35 USC 102 Novelty (BERT): 0.5664608018492008
- Combined Prediction Score: 0.8365325565334144
- Mean Citation Score: 499.71820400000007
- Max Citation Score: 544.04443
- Similarity Product: 270.16662809001

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test